drugset / Trial / NCT03809442

Analgesic Efficacy of Ropivacaine Alone or in Combination With Adjuvants on Post-operative Analgesia Following Video-Assisted Thoracoscopic Surgery.

NCT03809442

Phase 4 Completed 116 enrolled Aga Khan University
RandomizedParallel-groupTriple-blindTreatment

Summary

The aim of the study is to investigate the analgesic effects of the subcutaneous wound infiltration with tramadol, ketamine, dexamethasone, dexmedetomidine and midazolam as adjuvant to ropivacaine, compared to ropivacaine alone in patients undergoing Video-Assisted thoracoscopic Surgery (VATS) procedures.

Timeline

Start
2019-06-25
Primary completion
2023-08-31
Completion
2023-08-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule 8 mg Subcutaneous
Subject Dexmedetomidine Other / unclassified 0.5 ug/kg Subcutaneous
Subject Ketamine Small molecule 1 mg/kg Subcutaneous
Subject Midazolam Small molecule 50 ug/kg Subcutaneous
Comparator Ropivacaine Other / unclassified 60 mg Subcutaneous
Subject Tramadol Other / unclassified 2 mg/kg Subcutaneous

Indications

No indication recorded.